000			01610 a2200469 4500
005			20250512213037.0
264		0	_c19831123
008			198311s 0 0 eng d
022			_a0305-7453
024	7		_a10.1093/jac/12.suppl_a.213 _2doi
040			_aNLM _beng _cNLM
100	1		_aMaslow, M J
245	0	0	_aCeftazidime therapy of infections caused by Enterobacteriaceae and Pseudomonas aeruginosa. _h[electronic resource]
260			_bThe Journal of antimicrobial chemotherapy _cJul 1983
300			_a213-7 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aCeftazidime
650	0	4	_aCephalosporins _xtherapeutic use
650	0	4	_aDrug Resistance, Microbial
650	0	4	_aEnterobacteriaceae Infections _xdrug therapy
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMicrobial Sensitivity Tests
650	0	4	_aMiddle Aged
650	0	4	_aPneumonia _xdrug therapy
650	0	4	_aPseudomonas Infections _xdrug therapy
650	0	4	_aPseudomonas aeruginosa _xdrug effects
650	0	4	_aSepsis _xdrug therapy
700	1		_aRosenberg, A
700	1		_aPollock, A A
700	1		_aPress, R A
700	1		_aSilverman, D
700	1		_aEl-Sadr, W
700	1		_aRichmond, A S
700	1		_aSimberkoff, M S
700	1		_aRahal, J J
773	0		_tThe Journal of antimicrobial chemotherapy _gvol. 12 Suppl A _gp. 213-7
856	4	0	_uhttps://doi.org/10.1093/jac/12.suppl_a.213 _zAvailable from publisher's website
999			_c6413375 _d6413375